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By use of intermediate cell products of immune hemolysis made with guinea pig complement components, Borsos and Cooper demonstrated the presence of C'I, C'2, C'4, and C'3 complex in the sera of CFW mice, and laid the foundation for the measurement of mouse C' (C pro) components (1). Rosenberg and Tachibana used an improved test for the titration of whole C 'm activity and found marked differences in hemolytic complement activity among inbred strains of mice (2) . Herzenberg et al. (3) identified a euglobulin, hO, in the sera of mice whose blood contained hemolytic C 'm (C'm-competent mice). Sera of C '~-incompetent mice lacked this protein (3). Erickson et al. subsequently showed that the presence of C 'm activity and the protein hO always segregated together and were determined by a single gene (4) . Cinader, Dubiski, and Wardlaw (5), and Urbach and Cinader (6) have investigated a similar, if not identical, protein which they called MuB1. In CrY-competent strains of mice they noted a higher concentration of MuB1 in the sera of adult males than in the sera of adult females. Nilsson and Miiller-Eberhard used gel diffusion techniques to show that this genetically determined component is analogous to human C'5 (7).
Terry et al. studied the C~I, C'2, Ct4, and C'3 complex activity of the sera of several strains of mice (8) . The CP3 complex will be referred to as the lateacting components or Ctm-EDTA. Component studies indicated that interand intra-strain differences in C ~m activity were not due to variation of C'I, C'4, or C~2 activity. The genetically deficient strains, however, contained no measurable CPm-EDTA activity. The sera of males of Ctm-competent strains had about 10 times as much C'~-EDTA activity as the sera of females of the same strains (8) . It thus seemed that both the genetic deficiency and the rePresent address: Massachusetts General Hospital, Boston. * Correspondence regarding this paper should be addressed to the Biology Branch, National Cancer Institute, National Institutes of Health, Bethesda, Md. 20014. 657 duced C 'm activity of the sera of females were due to a deficiency of at least one of the components acting after CJ1, CJ2, and C'4.
The study of genetic and hormonal control of complement may lead to a better understanding of the role of complement in a variety of biological processes (6, 9, 10) . Accordingly, we studied the effect of castration and the in vivo effect of exogenous testosterone and estradiol upon mouse complement. The results of this study indicate that the serum content of at least two of the late-acting complement components, tentatively identified as Ct5 and C%, is affected by castration and by these hormones. The course of homograft rejection in B10D2 "old line" male mice rendered doubly deficient by castration, was identical to that of control mice.
Materials and Methods
Mice.--Balb/c mice were obtained from the Animal Production Section of the National Institutes of Health. B10D2-Old/SnJ (B10D2 "old line") and B10D2-New/SnJ (Bt0D2 "new line") mice were obtained from the Jackson Laboratory, Bar Harbor, Maine; these strains are coisogenlc, differing only in that the "old line" is C'-deficient, the "new line," C'-competent.
Mouse Serum.--Mice were anesthetized with pentobarbital administered intraperitoneaUy, after which they were bled and killed by heart puncture. The fresh blood was placed in a centrifuge tube stored in an ice bath. Immediately after formation of the clot, the serum was collected and titrations were performed within 2-3 hr after the blood was obtained. Mice were used only for one bleeding.
Materials.--Veronal-buffered saline (VBS), sheep erythrocytes (E), and rabbit antibody to boiled stromas of sheep erythrocytes (A) were prepared as described in reference 11 (p. 149-150). Techniques for the preparation of cellular intermediate products consisting of E. A, and guinea pig (gp) C' components are given in reference 11 (p. 200-201) . The preparation of VBS-EDTA (made by mixing 1 volume of 0.10 ~ NaB ethylenediaminetetra~cetate, pH 7.5-7.6, with 9 volumes of VBS lacking Ca ++ and Mg++) and of C'-gp-EDTA are described in reference 12. ttormones.--Aqueous testosterone (Oreton), given in the dosage of 2.5 mg per mouse, and estradiol benzoate in sesame oil (Progynon), given in the dosage 0.1 mg per mouse, were supplied by the Schering Co., Bloomfield, N. J. Controls were given Oreton vehicle (supplied by Schering) or sesame oil.
Complement Titratiom.--Whole complement: Sensitized cells (EA) were prepared by mixing a volume of E (1 X 109 cells/ml) with an equal volume of A. The diluent for both E and the A was VBS-EDTA buffer. The amount of antiserum used was 5-10 times the concentration of antiserum used to produce optimally sensitized cells for guinea pig C' titration. The sensitized cells (EA) were washed three times in VBS and brought to a concentration of 1 × l0 s cells/ml in VBS. 0.2 ml portions of EA, containing 2 X 107 cells, were mixed with 1.0 ml of serial dilutions of mouse serum, and the mixtures were incubated at 37°C for 60 rain with gentle mechanical agitation. About 4 ml of cold VBS were then added and the cells were collected by centrifugation. The superuatant fluids were discarded, the sedimented cells were lysed by addition of 3.0 ml distilled water, and the optical density of each lysate was measured at a wavelength of 412 m#. Titers are expressed as the reciprocal of the dilution of mouse serum giving 50o/o lysis (C'H50) and were calculated by means of the yon Krogh transformation (reference 11, p. 136).
C'1:C'1 activity was estimated by the ability of mouse serum to convert EAC'4 gp to EAC'la m, 4 ~p. 0.5 ml portions of EAC'4 ~p (1.5 X 108 cells/ml) were mixed with 0.5 ml of a dilution (from 1/10,000 to 1/80,000) of mouse serum and the mixtures were incubated for 15 rain at 30°C. 0.5 ml of purified C'2 ~p containing 100-200 effective molecules of C'2ZP/ EAC'4 Rp in VB-saline-sucrose (~ -0.009) was added to each sample and the mixtures were incubated for 10 rain at 30°C to convert EAC'la m, 4zP to EAC'la m, 4 ~p, 2a ~p. 4 ml of a 1/50 dilution of guinea pig serum in 0.01 M EDTA (C 'sp EDTA 1/50) were added to convert EAC'la m, 4 ~p, 2a ~p to E*. The mixtures were incubated at 37°C for 90 rain, and the extent of lysis was determined spectrophatometrically. Titers are expressed as the dilution of mouse serum giving 63% lysis (C'1H63).
C'2:
To estimate C'2 activity, sera were assayed for their ability to convert EAC'la ~p, 4 sp to EAC'la gp, 4 gp, 2a m. At zero time, a volume of EAC'la gp, 4 gp (1.5 X 108 ceils/ml) was mixed with an equal volume of mouse serum diluted 1/400 in VBS and the mixture was incubated at 30°C with gentle mechanical agitation. At convenient times 0.5 ml samples of the mixture were withdrawn, mixed with 4.0 ml of C'~P-EDTA 1/50, and incubated at 37°C for 90 rain to convert EAC'4 gp, 2a m to E*. Maximum generation of EAC'4~P, 2a m was achieved at 5 rain (t~x --5 rain). Sera were compared on the basis of the fraction of cells lysable at tmsx by C'~P-EDTA.
C'4:
Estimation of the C'4 content of mouse serum was based on the ability of the serum to generate sites in the state SAC'la m, 4 m, 2a m from SA. The validity of this method rests on the observation that all mouse sera tested thus far contain similar amounts of C'1 and of C'2. Highly sensitized EA were made as in the method for whole C' titration. A volume of mouse serum, diluted 1/75, was incubated with an equal volume of EA (1.5 × 108 cells/ml) at 30°C with frequent mechanical agitation. 0.5 ml samples were withdrawn at convenient times and mixed with 4.0 ml of C'~P-EDTA 1/50. Incubation and determination of lysis were performed as in the preceding section. Maximum generation of EAC'Ia m, 4 m, 2a m occurred at 2 rain (t~ --2 rain).
C"~-EDTA: C'm-EDTA activity of mouse serum was determined by its ability to generate E* from EAC'4 sp, 2a gp in the presence of EDTA. The intermediate product EAC'la ~p, 4 sp (1 X 10 s cells/m1) was mixed with 2 volumes of purified C'2 sp and incubated at 30°C for 7 rain. A large volume of ice cold 0.01 ~ EDTA was added and the cells were collected by centrifugation in the cold. The supematant fluid was discarded and the ceils were resuspended in 0.01 xt EDTA to a concentration of 1.5 X 108 ceils/m1 and maintained at 0°C. For titration, 0.2 ml aliquots of EAC'4 ~p, 2a ~p were placed in 13 X 100 ram test tubes at 0°C. To these were added 0.2 ml of serial dilutions of mouse serum in 0.01 x~ EDTA. The reaction mixtures were incubated at 37°C for 90 rain with frequent agitation. About 3 ml of cold 0.01 • r EDTA were added and the ceils were collected by centrifugation. The extent of lysis was determined as described in the method for whole C' titration. Titers are expressed as the reciprocal of the dilution of mouse serum causing 50% lysis (C'm-EDTA H50). Different lots of EACh4 sp, 2a sp vary in their susceptibility to lysis by C'-EDTA. Therefore, all titers were corrected to that of a standard lot of pooled guinea pig serum. In some experiments where high concentrations of mouse serum were used, the mouse serum was diluted in VBS and the EAC'4gP, 2aZP were suspended in 0.02 ~r EDTA to give a final concentration of 0.01 M EDTA in the reaction mixture.
Titragon o/C5 and C'6:0.2 ml of serial dilutions of test serum were mixed with a constant amount of appropriate reagent (see Results). The final dilution of reagent was the same in each reaction mixture. The C'5 or C'6 titer was calculated from the fraction of cells lysed in each mixture. Titers are expressed as reciprocal of dilution of serum giving 50% lysis. All calculations were based on the final dilution of test serum before addition of indicator ceils. In contrast to C 'm assays, no attempt was made to correct for the day to day variation in EAC'4 sp, 2a sp suspectibility to lysis. performed through posterior flank incision; orchiectomies, through a single scrotal incision. Controls consisted of mice from which only one gonad was removed, mice which were sham castrated, and untreated mice. At intervals after castration, the hemolytic activity of the late-acting complement components (C'm-EDTA) of individual mice was assayed. As the weanling mice matured, there was a rise in C'=-EDTA activity of the sera of control male animals. The C'~-EDTA activity of the sera of castrated male mice stayed at a low level throughout the course of the experiment (Fig. 1) . By 1 wk after castra-tion, the sera of adult male mice contained significantly less Ct=-EDTA activity than those of the controls. Like the sera of castrated weanling males, the C~=-EDTA activity of sera of castrated adult males remained, throughout the period of observation (4 months) at a low level of activity similar to that normally found in sera of control adult females. The C'm-EDTA activity of sera from castrated females (weanling or adult) was slightly but significantly increased after 60 days following castration. There was no correlation between C'=-EDTA activity and the weights of the mice at the time of bleeding.
The activities of Cq, C'2, and C'4 were determined in normal and castrated male mice. The data in Table I show that castration has no significant effect on the activities of these components. The low C"m-EDTA activity of castrated male and normal female mouse serum could be due to the presence of an inhibitor. Evidence against this hypothesis was obtained by the observation that the CPm-EDTA activity of the serum of normal Balb/c males was not inhibited when this serum was mixed with increasing concentrations of the sera of either Balb/c female or castrated Balb/c male mice (Table II) .
Effect, In Vivo, of Exogenous Testosterone and Estradiol on CP'~-EDTA Ac-
tivity.--Testosterone and estradiol were administered to castrated and normal mice of both sexes. 4 days after a single injection of testosterone there was an increase in the C'=,EDTA activity of the sera of castrated male mice. By the 8th day the level of C'=-EDTA activity reached one-half that of normal mate adults, but by the 17th day CI=-EDTA activity fell to levels observed before hormone treatment. Normal and castrated male and female mice were given weekly injections of testosterone. The C'=-EDTA activity of the sera of all these mice was increased. The sera of a similar group of animals receiving weekly injections of estradiol instead of testosterone had reduced C/=-EDTA activity (Table III) . A volume of serum 1 at the dilutions shown was mixed with an equal volume of serum 2 at the dilutions shown. Each mixture was tested for C'm-EDTA hemolytic activity.
M: Normal male; F: normal female; and CM: castrated male. Control mice were given either testosterone vehicle or sesame oil, neither of which affected C'm-EDTA activity. In vitro treatment of sera with these hormones had no effect on the activity of the late-acting components.
Assay of C'5 in Mouse Serum.--Assays of C'5 were based on the ability of samples to supply C'5 to the sera of B10D2 "old line" male mice, which lack this component (7) . The adequacy of this serum as a reagent for measuring C'5 depends on the assumption that this serum lacks only C'5 and on its ability to furnish all other components at concentrations which do not limit the reaction. To test for this requirement, samples were assayed for C'5 content with three different high concentrations of reagent serum. The data in Table IV show that C'5 content titers were independent of the concentration of reagent. Data were also plotted according to the equation for a one step reaction (14) . Data plotted according to this equation will yield a straight line if a single complement component is the independent variable, and all other components are supplied either in constant amount or in excess (Fig. 2) . The straight lines representing mixtures of reagent serum and test serum provide evidence in favor of a one step reaction. This was interpreted to mean that the assay was a measure of a single molecular species, C'5.
Assay of C'6 in Mouse Serum.--Neither rabbit serum lacking C'6 (13) nor mouse serum lacking C'5 is hemolytically active. A mixture of these two sera has hemolytic activity. Consequently the serum of "old line" mice must contain at least CI6. We used the C'6-deficient rabbit serum as a reagent to assay C% activity in mouse sera. The Ct6 titers of sera from "old line" females, B10D2 "new line" females, and Balb/c females were less than ~ of the C'6 titer of sera from male mice of these strains.
The C'6-deficient rabbit serum, however, is not an ideal reagent for the assay of mouse C'6 because it inhibits the Ctm-EDTA activity of sera from Balb/c mice (Table V) . This observation is consistent with the possibility that C'6-deficient rabbit serum contains a factor or factors which inhibit the hemolytic activity of mouse serum. 13 pools of C%-deficient rabbit serum were tested and 0.2 ml of serial dilution of test serum were mixed with 0.2 ml of reagent at a constant concentration (final dilution of reagent = ~). All liters were calculated from the absolute dilution of test serum in the reaction mixture before addition of indicator cells. all were inhibitory. In addition, data from assays using C'6-deficient rabbit serum as reagent did not yield a straight line when plotted according to the equation for a one step reaction (Fig. 3) . This latter finding is consistent either with the presence of an inhibitor in C'6-deficient rabbit serum or with the possibility that more than one component is limiting.
These experiments with C'6-deficient rabbit serum showed that Balb/c female serum is relatively depleted in C%. Consequently we thought that Balb/c female serum might be used to assay C'6. The adequacy of this serum as a reagent for measuring C% depends on the assumptions that it supplies all components except C'6 in amounts which do not limit hemolysis and that the C% from the reagent serum does not contribute significantly to the C'6 titer. To test for this requirement, aliquots of serial dilutions from one pool of male Balb/c mouse serum were mixed with a constant concentration of reagent serum (Balb/c female). The fiter of these mixtures was independent of the concentration of reagent serum employed (Table VI) . These data were also plotted according to the equation for a one step reaction. The data in Fig. 3 show that assay for C"6 with Balb/c female serum as reagent yielded a linear dose response curve. This finding is consistent with the conclusion that only one component is limiting in this assay.
Based on the evidence described in this section, we tentatively identified the component which is measured with Balb/c female serum as C"6. This identification is only tentative because more than two of the late-acting components may be affected by sex hormones.
The C'5 and C'6 Content of Sera from Normal and Castrated Mice of Both
Sexes.--A mixture consisting of serum from Balb/c females and the nonhemolytic serum from genetically C'5-defident male mice had about eight times as much whole C' activity as the serum of the Balb/c female alone (Table VII) . Similar results were obtained in experiments in which C'm-EDTA activity in-stead of whole C' activity was measured (Table VIII) . These observations were interpreted to mean that at least one of the C t components responsible for the male and female difference in complement titer is a late-acting component distinct from C'5.
We assayed the C~5 and C% content of sera from normal and castrated mice of both sexes. The data summarized in Table IX show that sera from male Volumes of test serum were mixed with equal volume of reagent shown in column under Reagent, and the mixtures were serially diluted to assay complement activity. All titers are calculated from the absolute dilution of test serum in the reaction mixture before addition of indicator cells.
M: Normal male; and F: normal female.
Balb/c mice contain about three times more C'5 and about six times more C'6 than sera from female Balb/c mice contain. The C'5 and C'6 titers of sera from castrated male mice fell to levels usually found in sera from female mice. In sera from castrated female mice, the C'5 and C'6 titers rose to a level intermediate between the titers of a normal male and normal female.
Comparison of the change of C'5 and C% titers after castration shows that C'6 titer is affected to a greater extent than the Cr5 titer. Furthermore the change in C% titer after castration more closely parallels the changes observed in C'm-EDTA activity after castration than does the change in C'5 titer (Table   IX) . Volumes of test serum were mixed with equal volumes of reagent shown in column under Reagent, and the mixtures were serially diluted to assay complement activity. All titers are calculated from the absolute dilution of test serum in the reaction mixture before addition of indicator cells.
M: normal male; CM: castrated male; and F: normal female. CP5 was assayed using sera from B10D2 "old line" mice as reagent (~). Cr6 was assayed using sera from Balb/c females (~). All mice were castrated 6 months before these assays were performed. The Effect, In Vivo, of Exogenous Testosterone and Estradiol on C'5 and C'6 Activity.--Both male and female B10D2 mice of the "old" and "new" lines were given testosterone or estradiol. Control mice were given the appropriate vehicle. All animals received four subcutaneous injections equally spaced over a 2 wk period. The sera of the "old line" mice were assayed for C'6 and the sera from "new line" for C'5. The results of these experiments are summarized in Tables X and XI and show that the activity of both C'5 and C'6 is increased by administration of testosterone and depressed by administration of estradiol. The results are consistent with earlier observations on the effect of these hormones on whole C'm-EDTA activity. The Rejection of Homografts by Mice Deficient in C'5 and C'6.--Mice deficient in C'5 (B10D2 "Old line," DBA/2) have normal Arthns reaction (15, 16) , normal homograft rejection (15, 16) , normal phagocytic activity (17) , and normal herd immunity (18) . These mice, deficient in C'5, can be made relatively deficient in C'6 by castration. We have studied the course of homograft rejection in animals deficient in C'5, in animals deficient in C'5 and C'6, and in normal animals. The skin grafts were taken from male Balb/c mice, a strain which is H2 compatible with the recipient mice. Approximately 1 cm ~ full thickness skin grafts were held in place with metal clips. For the first 4 days the grafts were protected with Band Aids. The day of complete escharification of the graft was recorded as the day of graft rejection. The results, summarized in Table XII, show that there was no significant difference in the time of rejection of skin in all four groups of mice. DISCUSSION We have reported that the administration of testosterone or estradiol to mice influences the titer of at least one of the serum complement components which act after the first, second, and fourth components (9) . The overall titer of these late-acting components (C'm-EDTA), usually 8-10 times greater in males than in females, increased 1.5-4 times after treatment of mice with testosterone. The C'm-EDTA titer of the serum of castrated males or males treated with estradiol fell to levels normally found in intact female mice. We have developed assays for two of the late-acting components, and have shown that both of these components are affected by castration and by the adrninistration of testosterone and estradiol. Identification of both these components required the use of serum deficient in one complement component. Serum from B10D2 "old line" mice were used to identify one component. B10D2 "old line" mice are thought to lack C~5 on the basis of gel d~usion studies. Until the possibility that sera from these mice lack other components as well has been excluded, identification of one of these two late-acting components as CP5 is uncertain. Identification of the other component as Ct6 required the use of C~6-deficient rabbit serum and is subject to some uncertainty because of evidence which raised the possibility of a complement inhibitor in the C'6 rabbit serum. Whether the inhibitory effect of the C'6-deficient serum is due to the presence of an inhibitor or the result of mixing rabbit and mouse components is not known. In either case the inhibitory effect precludes use of this reagent to measure the component distinct from CP5 which is affected by sex hormones. Balb/C female serum may be used in place of C'6 rabbit serum and can be used to measure a component distinct from C~5. This component is tentatively identified as C~6. Late-acting components other than these two may be affected by sex hormones, but their identification awaits the development of suitable assays.
TABLE X

Effect, In Viro, of Exogenous Testosterone and Estradiol upon the C15 Content of Mouse Seva
To obtain evidence that only one component was being measured in these assays, the data were evaluated by use of the equation for the one step reaction which, in turn, is based on the single site theory of immune hemolysis (14) . Linear plots, indicating that only one component was limiting, were obtained from data of assays of CP5 and C'6 with mouse reagents. Using these assays we have found that the titer of C'5 in sera of male mice is two to four times greater than the titer of this component in female mice. The titer of C'6 in sera of male mice is 6 to 12 times greater than the titer of this component in female mice.
The differences in C'5 content of sera of male and female mice are not sufficient to account for the observed difference in C'm-EDTA titer of mouse sera since the Ctm-EDTA titers of the male sera may be 10 times higher than those of female sera. Based on these observations, we propose that the sex differences and the changes caused in C'm-EDTA levels by hormone treatment or castration are mainly due to differences and changes in serum content of a component other than C'5, presumably C'6.
MuB1 is thought to be C'5 (7). Urbach and Cinader have measured the concentration of MuB1 in mouse sera (6) by a single diffusion ring test (19) . These workers found that the concentration of MuB 1 in normal males was about twice as high as that of normal females. The concentration of MuB1 in sera from castrated males approached the level found in normal females. Administration of testosterone to normal male and female mice and to castrated male and female mice increased the MuB1 concentration in the sera of these animals two-to threefold. Our findings, based on the hemolytic assay of C'5, are in agreement with their results.
These authors also found that estradiol caused a slight but significant increase in the MuB 1 concentration in the sera of all mice except in the sera of sham-operated male mice. In contrast we observed that estrogen depressed the concentration of C'5. The cause of the discrepancy between Cinader's findings and ours is unknown but may be due to differences in mice, dose schedules, and assays. In addition, the possibility cannot be excluded that MuB1 and C'5 are two distinct molecules.
The administration of testosterone increased and the administration of estradiol decreased the C'6 titer of B10D2 "old line" mice which lack C'5 on a genetic basis. Sera from B10D2 mice, genetically deficient in C'5, did not acquire hemolytic activity after these mice were treated with large doses of testosterone. The C'6 titer in sera of C'5-deficient mice, however, increased in the expected manner after testosterone treatment.
Homograft rejection is the only biological process which we have studied in mice deficient in these two complement components. Despite the absolute deficiency of C'5 and the relative deficiency of C'6, the course of homograft rejection was unchanged in these mice.
SUMMARY
The titer of late-acting complement components in sera from male mice is 8-10 times higher than the titer of sera from female mice. Using assays developed to measure the serum content of two of the late-acting components, we have shown that this difference is due to the effect of androgen and estrogen on these two late-acting complement components. These two components have been tentatively identified as Ct5 and C%. Androgen and estrogen have greater effect on C% than on C'5. The possibility has not been excluded that still other of the late-acting complement components are affected by androgens and estrogens.
The course of homograft rejection was unchanged in mice deficient in C'5 and C'6.
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